This inventor holds 3 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1993-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bad Bellingen, DE (1993 - 1995)
- Ihringen, DE (1997)
Company Filing History:
Years Active: 1993-1997
Title: Ute Isele: Innovator in Pharmaceutical Formulations
Introduction
Ute Isele, a noted inventor located in Bad Bellingen, Germany, has made significant contributions to the field of pharmaceutical formulations. With a total of three patents to her name, Isele's work focuses on innovative dosage forms that enhance the administration and efficiency of therapeutic compounds.
Latest Patents
Among her latest inventions is a patent for “Intravenous solutions for a derivative of staurosporine.” This invention presents a novel dosage form for sparingly soluble staurosporine derivatives, particularly N-benzoyl-staurosporine. The formulation is designed as a nanoemulsion for intravenous administration, utilizing a combination of phospholipids, triglycerides, and partial fatty acid esters of polyoxyethylene sorbitan as solubilizers.
Another noteworthy patent is the “Parenterally administrable liposome formulation comprising synthetic.” This invention relates to pharmaceutical compositions that feature parenterally, especially intravenously, administrable liposome dispersions or dry preparations. The compositions include a zinc-phthalocyanine complex along with synthetic, substantially pure phospholipids, showcasing her innovative approach to drug delivery systems.
Career Highlights
Ute Isele's career is prominently marked by her role at Ciba-Geigy Corporation, where she collaborates with fellow inventors to advance pharmaceutical innovation. Her work has significantly impacted the development of drug formulations, leading to more effective clinical applications.
Collaborations
Throughout her career, Isele has had the opportunity to work alongside distinguished colleagues, including Peter Schneider and Peter Van Hoogevest. These collaborations have fostered a creative environment, enabling shared knowledge and expertise in the intricacies of pharmaceutical science.
Conclusion
In summary, Ute Isele is a pioneering inventor in the realm of pharmaceutical innovations. Her dedication to improving drug formulations through her patents exemplifies her commitment to advancing healthcare solutions. Isele's contributions continue to shape the landscape of medical treatment and highlight the importance of innovative thinking in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile